REVERSAL OF ANTICOAGULANT EFFECT OF DABIGATRAN BY PROTHROMBIN COMPLEX CONCENTRATE (BERIPLEX) ASSESSED WITH A NOVEL METHOD OF BLOOD LOSS MEASUREMENT
Phase of Trial: Phase II
Latest Information Update: 26 May 2016
At a glance
- Drugs Dabigatran etexilate (Primary) ; Prothrombin complex concentrate (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 10 May 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016.
- 10 May 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jul 2016.
- 14 Jan 2015 New trial record